rabeprazole has been researched along with Disbacteriosis in 3 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Son, M | 1 |
| Park, IS | 1 |
| Kim, S | 1 |
| Ma, HW | 1 |
| Kim, JH | 1 |
| Kim, TI | 1 |
| Kim, WH | 1 |
| Han, J | 1 |
| Kim, SW | 1 |
| Cheon, JH | 1 |
| Nadatani, Y | 2 |
| Watanabe, T | 2 |
| Suda, W | 1 |
| Nakata, A | 1 |
| Matsumoto, Y | 1 |
| Kosaka, S | 1 |
| Higashimori, A | 1 |
| Otani, K | 2 |
| Hosomi, S | 2 |
| Tanaka, F | 2 |
| Nagami, Y | 2 |
| Kamata, N | 2 |
| Taira, K | 2 |
| Yamagami, H | 1 |
| Tanigawa, T | 2 |
| Hattori, M | 1 |
| Fujiwara, Y | 2 |
| Takashima, S | 1 |
| Kawaguchi, Y | 1 |
| Usui, Y | 1 |
| Fujimoto, K | 1 |
| Imoto, S | 1 |
| Uematsu, S | 1 |
3 other studies available for rabeprazole and Disbacteriosis
| Article | Year |
|---|---|
Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function.
Topics: Animals; Benzene Derivatives; Colitis; Dysbiosis; Imidazoles; Inflammation; Inflammatory Bowel Disea | 2022 |
Gastric acid inhibitor aggravates indomethacin-induced small intestinal injury via reducing Lactobacillus johnsonii.
Topics: Animals; Disease Models, Animal; Dysbiosis; Fecal Microbiota Transplantation; High-Throughput Nucleo | 2019 |
Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in mice.
Topics: Animals; Corticosterone; Dysbiosis; Gastrointestinal Microbiome; Intestinal Mucosa; Male; Mice, Inbr | 2020 |